PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
-
Upload
armida-stickney -
Category
Documents
-
view
216 -
download
0
description
Transcript of PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
-
PROPOSED DRAFT
PROTOCOL CARE FOR PATIENTS
WITH MULTIPLE CHEMICAL
SENSITIVITIES OR CHEMICAL
INJURY An "Undefined Illness"?
10/18/2014
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
1
A PERSON WITH MULTIPLE CHEMICAL SENSITIVITY (MSC) SHOULD READ THIS DRAFT PROTOCOL AND DISCUSS IT
THOROUGHLY WITH HIS/HER PHYSICIAN AND ATTENDING CAREGIVER(S) TO MAKE ANY NECESSARY MODIFICATIONS
OR THE LIKE. DRAFT PROTOCOL STARTS ON
PAGE SIX (6).
WHEN ENCOUNTERING A PERSON (prospective patient) with (MCS) or Chemical Injury or Chemical Intolerance, this is what you should know:
Overview | Multiple Chemical
Sensitivity (MCS) is the name given to
a syndrome in which a sufferer
experiences multiple symptoms upon
exposure to minute amounts of
everyday chemicals. There is currently
no officially recognized definition for
MCS. This is due to the fact that it is
becoming pervasive but the political
will to pin point the causes to petro-
based compounds used in many
common consumer products is
lacking. Thus, it is claimed that very
little is known about it, especially the
mechanisms involved with the onset
of symptoms.
To circumvent the "elephant in the
room," there are theories to suggest
a possible role for a hypersensitive
central nervous system, immune
dysfunction and impaired
detoxification by liver enzymes. Some
medical professionals, and even
organizations, continue to insist that
the syndrome is psychological in
origin, even in the face of a growing
amount of evidence from studies that
show clear abnormalities in people
with MCS on exposure to normally
safe levels of chemicals. Through
1999 there were a total of 618
scientific articles, editorials, books,
book chapters and reports relating to
MCS. Of these, 308 supported an
organic/physiological basis for
symptoms whereas only 137
supported a psychological
interpretation.
Although there is no definition
universally accepted by the
established medical institutions since
1999, MCS experts (Bartha et al 1999)
have come to a consensus on the
criteria for diagnosis, and thus far
these criteria remain unrefuted in the
published literature.
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
2
These criteria are as follows:
The symptoms are reproducible
with [repeated chemical] exposure.
The condition is chronic.
Low levels of exposure [lower than
previously or commonly tolerated]
result in manifestations of the
syndrome.
The symptoms improve or resolve
when the triggers are removed.
Responses occur to multiple
chemically unrelated substances.
Symptoms involve multiple organ
systems.
MCS/Toxic Injury is NOT a result of
an allergen. It is a result of exposure
to a toxin/toxicant.
In brief, MCS is an acquired chronic
disorder characterized by recurrent
symptoms in response to exposure
to multiple, unrelated chemicals
("chemical cocktails") in the
environment. The symptoms
generally occur in one of four
categories: central nervous system,
circulatory, respiratory, and hepatic,
including liver and spleen.
Moreover, as of 2011, the prevalence
of MCS of the U.S. population was at
13 percent (approximately 40
million). This calls for informed
medical help for people with
chemical sensitivities. Missed
diagnosis of chemical sensitivities
may result in incorrect treatment
and possible iatrogenic
harm resulting from the activity of
physicians; said of any adverse cond
ition in apatient resulting from treat
ment by a physician or surgeon.
Symptoms | Many MCS sufferers can
trace the start of their illness to an
acute exposure to highly toxic
chemicals (Gulf War veterans, and
farmers using pesticides for example).
For other sufferers the illness
develops over a long period of time
most likely involving chronic low level
exposure to chemical substances.
Although MCS can occur on its own, a
large number of sufferers also suffer
from CFS, Fibromyalgia and other
related disorders. This obviously
points to the possibility that all these
illnesses are part of the same
underlying process and likely have
common causes.
MCS is a chronic condition with the
patient usually experiencing some
level of "unwellness" all the time.
However, patients have an acute
reaction when exposed to minute
amounts of the chemicals to which
they are sensitive. Often the level of a
chemical that triggers a reaction may
be so low that the sufferer cannot
even smell it.
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
3
Common symptoms of MCS upon
exposure:
Fatigue
Headaches
Disorientation
Dizziness and faintness
Flu-like symptoms
Memory loss
Visual problems
Nausea
Irregular or rapid heartbeat
Muscle and/or joint pain
Gastrointestinal problems
Mood disturbances such as
depression/anxiety/irritability
Short-term altered mental status
Asthma/Breathing Problems
Rashes
Difficulty concentrating
Flushes
Most sufferers have a distinct reaction
upon every exposure. It is common to
first experience dizziness,
disorientation, rapid heartbeat and
mood changes followed by flu-like
illness and muscle/joint aches. In
severe cases, the flu-like illness and
aching can persist for days.
Triggers | Reactions in MCS are
triggered by a vast array of everyday
chemicals from perfume to diesel
exhaust. The common ingredients in
most of these chemical products are
hydrocarbon based volatile organic
chemicals (VOCs). Phenols (containing
benzene) are commonly implicated.
With everyday cosmetic and
household chemical products, it is
generally the addition of perfume that
makes them bad news for MCS
sufferers. Typically a sufferer will
notice a sensitivity to one or two
things to start with, perfume and
cigarette smoke for example, and then
will rapidly become sensitized to
more and more chemical sources over
a relatively short period of time. The
reasons for this common occurrence
are unknown but it is clearly
something that needs to be
investigated.
Common triggers in MCS are
pesticides (e.g., organophosphates
and organochloridesDDT,
chlordane, lindane, dieldrin)
fragrances (perfume) (benzaldehyde,
benzyl acetate, benzyl alcohol,
camphor, ethanol, ethylacetate,
limonene, linalool, a-pinene, g-
terpinene, a-terpineol,
dichlorobenzene); note that all of
these chemicals are known to have
negative health consequences, mainly
due to effects on the central nervous
system
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
4
gasoline | vapors cause central
nervous system depression, including
eye and respiratory irritation,
dizziness, headache, drowsiness, and
incoordination
vehicle exhaust | major exhaust
fumes include carbon monoxide,
nitrogen dioxide, sulphur dioxide,
benzene, formaldehyde, polycylic
hydrocarbons, and suspended
particles (PM-10)
household cleaning products,
dishwasher detergent, including
laundry liquid/powder, fabric
softener, air fresheners, and
bathroom/kitchen detergents |
common chemicals include diethyl
phthalate, toluene, hexane/xylene
personal care products & cosmetics
including shower gels and liquid
soap, nail varnish, hair styling
products, hair conditioners, sun
lotions, scented soaps | some of the
common chemicals include cocoamide
DEA, sodium lauryl sulfate, acetone,
benzaldehyde.
Other triggers include cigarette
smoke, natural gas, new carpets made
with benzene derivatives,
formaldehyde and the like, particle
board, marker pens, soft plastics,
newspapers/magazine, paint, varnish,
solvents, glues/adhesive, food
additives and preservatives,
medications, unfiltered waterand
more.
This list is not all inclusive.
Impact on Quality of Life | As a
devastating illness, an MCS sufferer
typically becomes more and more
isolated and withdrawn as they simply
cant be around people (wearing
perfume, deodorant etc.) or in public
spaces where chemicals are routinely
used. MCS sufferers often lose their
jobs as they cannot tolerate the
chemicals in the work environment,
and relationships often break down as
the partner is unable to understand or
adapt to living without the use of
common chemical products. To add
insult to injury, because of the current
medical confusion over the illness,
patients often have to endure being
labelled as attention seekers or
hypochondriacs, as well as having to
fight, often in court, to be granted
disability benefits and appropriate
housing.
NOTE: If the primary doctor doubts
that Multiple Chemical Sensitivity is
NOT physiological and believes the
roots are psychological, that doctor
is not an appropriate health care
provider for the person with MCS.
Such a doctor can do more harm
than good and needs to do further
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
5
research on recent findings that
point to physiological origins.
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
6
DRAFT
PROTOCOL
o Reassure the patient that you
understand he/she is sensitive
to chemicals and will work with
him/her in providing care.
o Be sure to ask what exposure(s)
she/she recently encountered.
o Be sure to ask what the patient
is sensitive to, including his/her
history of reactions to various
drugs you may consider to
administer.
NOTE: Persons with MCS are
the experts related to their
own needs and requirements.
Therefore, it is important to
have the patient involved in
the development of their care
plan.
A comprehensive assessment is
required, and the medical
history may be extensive as MCS
affects many systems.
o Take into consideration the five
stages of grief or loss of good
health and determine which
stage the patient is in regarding
his/her condition
(1) denial and isolation
(2) anger
(3) bargaining
(4) depression
(5) acceptance
o Carefully note environmental
sensitivities, food and drug
allergies and their reactions.
Note how the patient copes with
his/her MCS as it varies
dependent on the actual
sensitivities specific to that
patient. Include what specific
equipment they use, their usual
medications or remedies,
alternative measures or oxygen.
o Determine if oxygen therapy is
required and prescribe it.
o Place a high-alert allergy band
on the patient and mark it
MULTIPLE CHEMICAL
SENSITIVITY (MCS).
o Educate the caregiver(s) to the
patient's condition of MCS.
o Discuss diet needs of patient
and indicate on diet order that
the diet is a special-needs diet
for MCS. Only pure food should
be served that do not contain
preservatives, dyes, colorings,
MSG, aspartame, or other GRAS
foods (e.g., margarine).
o Consult a dietician for dietary
needs; retain dietary
requirements in the patient's
medical record for future
reference.
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
7
o Allow patient to supply his/her
own tolerated food products
and dietary supplements.
o Assign a private room with
negative pressure if available.
Do not use a room that has
been recently exposed to any
type of fragrance or VOCs.
Maintain patient isolation from
other patients and their visitors
at all times.
o A room without carpeting is
essential for the safety of the
patient.
o Change the linens on the bed
that are fragrant-free (e.g.,
without any Febreze fabric
softener). Not all so-called
scent-free products are toxin
free!
o Flag the patient's chart or other
written information that he/she
is chemically sensitive.
o Whenever possible, take the
patient's own medical supplies
and equipment with them,
including oxygen mask and
tubing, medications, food and
water, bedding, clothing, and
soap. He/she may be sensitive
to such items issued at a
shelter, hospital, or clinic.
o If drugs are administered
(1) administer low doses with
caution and keep them as
simple and as minimal as
possible;
(2) use IV fluid bottled in glass
without dextrose if possible
(many persons react to corn-
based dextrose);
(3) capsules are generally better
than tablets because they have
fewer binders, fillers, and dyes;
(4) if administering anesthesia,
use short-acting regional rather
than general anesthesia
whenever possible and avoid
the use of halogenated gas
anesthetics.
o Consult with the patient's
environmental physician or
acupuncturist if possible.
o If the patient is taken to an
emergency shelter or a hospital,
help protect him/her from air
pollution. Some suggestions
(1) avoid placing the patient in
rooms with recent pesticide
sprays, strong scented
disinfectants, cleaners, new
paint or carpet, other recent
remodeling, a recent patient
wearing any fragrance;
(2) place a sign on the door,
stating the patient inside has
MCS; and add ""Check at the
nurses' station before entering
the patient's room";
(3) assign caregivers* who are
not wearing fragrances (e.g.,
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
8
perfume, fabric softener,
Febreze on clothes, and who do
not smoke);
(4) allow the patient to wear a
mask or respirator, nebulizer,
use oxygen mask, or an air
filter, or open a window as
needed;
(5) keep the door to the
patient's room closed
(6) reduce time the patient
spends in other parts of the
hospital, if possible, by
performing as many procedures
and evaluations as possible in
his/her room;
(7) transport patient with P95
mask or personal respirator.
* Caregivers: Staff caring for
patient is to refrain at all times
from wearing perfumes,
scented lotions, hair spray,
scented shampoo, deodorants,
or scented products and use
only unscented soap to wash
their hands. Staff should also
be aware that the laundry
soaps and fabric softeners
they use to wash their
uniforms will affect the patient
and should not use these
products when caring for any
patient with MCS! In fact, all
members of the medical team
should be fragrance-free,
especially in regards to
scented clothing, colognes, and
the like.
o Obtain Purple Nitrile Medical
Exam Powder Free Glove Kit and
place in room.
o Do not use any Sharpie writing
instruments or the like that
have a strong odor.
o Order a bottle of hydrogen
peroxide to use as skin prep for
IV initiations and phlebotomies.
o If patient requires oxygen, open
tubing, mask, or prongs
package, "air out the item(s)
before use with patient. Wipe
the mask/prongs, and tubing
with hydrogen peroxide and
flush the tubing with oxygen or
medical air prior to applying to
patient. These actions are
necessary to dissipate the scent
of the plastic.
o Keep the use of plastic to a
minimum. Use paper tape
instead of plastic tape.
o Allow the patient, or provide,
purified water for drinking.
o Do not allow open containers
with chemical to sit in the room.
o No plants, flowers, magazines,
newspapers are to be placed in
the patient's room as they emit
VOCs.
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
9
o Whenever possible, ensure that
the air is fresh (not artificially
"fresh").
o Utilize charcoal and baking
soda to absorb and remove
odors from the room. Open
windows if possible.
o Communicate and cooperate
with the patient whenever
possible as the patient generally
knows what will help.
o Observe the patient for the
following symptoms
o fatigue
o memory loss
o depression
o nervousness
o lack of motivation
o visual problems
o hearing problems
o dizziness
o sleep disorders
o edema
o inflammation of head
tissue
o syncope
o spastic muscles (.2
mEq/kg of magnesium
over a 4-hour period daily
may relieve spasms)
o pulling parathesias
o hypoesthesia
o hyperventilation
o seizures
o asthma
o severe anaphylaxis
o disorientation
o confusion
o irritability
o hoarseness
o loss of coordination
o loss of logic sequencing
ability
o shortness of breath
o headache
o chest pain
o joint pain
o digestive difficulties
o tingling sensations in any
part of the body
o numbness of extremities
o digestive difficulties
o cold or heat sensitivity
o rashes
o nausea
o sinusitis
o rhinitis
o pallor
o anemia
o hives
o any other symptom
Report to physician any signs
and symptoms exhibited by
patient.
o In case of surgery, test Betadine,
tape, and suture material 48
hours prior to surgery to
observe any adverse reaction.
PRE-OP PROCEDURES
o Wash down operating room
with water and baking soda
solution to remove disinfectant
and pesticide odors.
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
10
o Ensure that the patient has been
prepared for surgery by
lowering his/her total load of
chemical exposures and
increasing his/her intake of
antioxidants, vitamins, and
minerals. High levels of vitamin
C before and during surgery
(1 to 4 grams every four hours)
helps to tolerate chemical
overload.
PRE-OP MEDICATIONS
o No oral medication if possible.
Avoid antihistamines and
steroids if possible. Benadryl or
an injection of 0.4 to 0.6 ml of
IM atropine may be used to
prevent excess secretions. Also,
Atarax is usually safe. Usually,
atropine or morphine-demerol
compounds are sufficient for
pain control. To alkalinize
stomach contents to reduce
problems with aspiration
pneumonitis, use Akla Seltzer
(without aspirin).
For intravenous fluids, use IV
0.45 normal saline in glass
bottles, not plastic. Soft
plastics, such as those used for
IV drips and blood bags contain
phthalates, which include many
toxic chemicals such as
hormone disrupters. These
chemicals leach into the IV
solution and can cause
reactions in the patient with
MCS. Glass bottled 45 NS
available from Merit
Pharmaceuticals ((800) 696-
3748). If dextrose or Ringer's
solution is used, observe for a
reaction due to its corn content.
For fructose and invert sugars,
contact company beforehand to
check formulations and sources.
ANESTHESIA
o Do not test anesthetic drugs
before use.
o All drugs should be checked for
preservatives.
o Sodium penathol, Versad,
Phyentanyl (long-acting opiod)
are recommended drugs for
induction and maintenance of
anesthsesia.
o The basis for anesthesia to work
well
(1) the patients inhales 100%
oxygen for five minutes;
(2) Bolus of sodium pentothal or
other short-acting barbiturate is
used for induction;
(3) followed by curare (a long-
acting morphine compound)
and a long-acting scopolamine
compound. Succinyl choline
chloride (Anectine) may also be
used to paralyze. Sublimaze
and Innovar can be used to
obliterate memory.
o For shorter procedures, the
patient may use the Brevitol
drip.
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
11
o Diprovan is recommended for
induction and/or regional
anesthesia.
o Use local anesthetics such as
preservative-free and
epinephrine-free xylocaine or
carbocaine whenever possible.
No halogenated hydrocarbons
(Fluothane, Ethrane, Penthrane).
The patient can get dramatically
worse with gas anesthetics. If
recovery occurs, it may involve
several days of recovery.
o Avoid inhaled anesthetic, if at
all possible, since the
fluorinated hydrocarbons and
nitrous oxide are known to be
immune-suppressants. If
required, nitrous oxide is to be
used only in as limited a level as
is possible.
SURGERY
o Do not use any dyes.
o Safe sutures are silk, cotton,
gut-lamb. Avoid synthetics.
o Recommended lab work for
surgeryCBC, urinalysis, SMA
20, liver function.
POST-SURGERY
o Antibiotics given intravenously
provoke fewer reactions than
orally administered antibiotics.
o In-line intravenous filters
should be used for higher
tolerances.
o Use TENS unit or acupuncture
for pain control. Vicodan may
be okay for pain.
FURTHER NOTES/MODIFICATIONS
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
12
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
_____________________________________
THE INFORMATION PROVIDED IS
NOT INTENDED TO BE A
SUBSTITUTE FOR A PHYSICIAN'S
CARE OR TREATMENT. CONSULT
WITH THE PHYSICIAN BEFORE
ACTING ON ANY OF THE
RECOMMENDATIONS. THIS DRAFT
PROTOCOL IS PROVIDED IN THE
ABSENCE OF A PROTOCOL THAT
SPECIFICALLY MEETS THE NEEDS OF
A PERSON WITH MULTIPLE
CHEMICAL SENSITIVITY.
IN FACT, THIS IS A CALL FOR AN
OFFICIAL PROTOCOL. THE CDC
NEEDS TO RECOGNIZE MCS AS A
SERIOUS PUBLIC HEALTH CONCERN.
According to a research study in 2011,
ninety physicians practicing in the
State of Virginia responded to a mail
survey regarding MCS, over half
believed chemical sensitivity to be a
combination of medical ("a chemical
exposure and genetics") and
psychological condition (resultant
response could be "depression,
generalized anxiety, posttraumatic
stress disorder, hopelessness"),
slightly skewed towards physiological
etiology. No physician endorsed a
purely psychological etiology.
The following statement should be
taken into consideration regarding a
June 2008 report published in "The
Journal of Environmental Health" on
"The Challenges of Multiple Chemical
Sensitivity" which noted the following:
Regardless of whether MCS is a
legitimate physiologic disease process
or not, giving it due consideration is a
-
PROTOCOL CARE FOR PATIENTS WITH MULTIPLE CHEMICAL SENSITIVITIES OR CHEMICAL INJURY
PROPOSED DRAFT FOR DISCUSSION PURPOSES
13
useful exercise for the public health
community. If proven scientifically
valid, MCS would significantly affect
public health in general and
environmental health specifically. MCS
could fundamentally alter our
understanding of pathophysiology,
affecting disease research design and
disease prevention measures. On a
much broader level, the government,
private sector, consumers, and general
population would be engaged in a
partnership that would benefit all of
public health. A nimble, adaptable
public health infrastructure benefits by
considering MCS and the state of
environmental health. It is an
important exercise to consider these
implications and the ability of public
health to respond. A public health
community that is unable or unwilling
at a minimum to contemplate
paradigm-altering possibilities neglects
its duty. With such significant
implications, neglect would be
insensitive.
Last but not least, every person with
MCS symptoms varies in severity as
well as symptoms due to a particular
chemical exposure. Some persons
have been suffering for a long time or
some are recently aware of certain
sources that are causing symptoms.
Find out if the person has had/has
extreme difficulties with any specific
chemical exposures. One person's
extreme may not be that of another's.
There cannot be any generalization of
MCS beyond the consensus criteria for
diagnosis. For an example, a person a
severe condition may not even be able
to tolerate an ink pen in her/his
surroundings. The symptoms may
vary according to the possible
multiple organs that may be afflicted.
It is vital to check a person's organ
health (e.g., heart, spleen, kidneys,
lungs, liver, skin).
Compiled from various online sources
(October 18, 2014)